In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit its desired safety ...
The news: Shares in Telix Pharmaceutical climbed in morning trade after the company reported positive results from a global phase 3 trial of its advanced prostate cancer treatment, TLX591. Shares ...
These shares are having a strong session on Tuesday. Let's find out why. The post Why Life360, St George Mining, Telix, and Westgold shares are charging higher today appeared first on The Motley Fool ...